131 related articles for article (PubMed ID: 6295273)
1. Efficacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine against different herpes simplex virus strains in cell culture and against experimental herpes encephalitis in mice.
Reefschläger J; Wutzler P; Thiel KD; Bärwolff D; Langen P; Sprössig M; Rosenthal HA
Antiviral Res; 1982 Oct; 2(5):255-65. PubMed ID: 6295273
[TBL] [Abstract][Full Text] [Related]
2. Treatment of experimental herpes simplex virus type 1 encephalitis in mice with (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil: comparison with bromovinyl-deoxyuridine and acyclovir.
Reefschläger J; Wutzler P; Thiel KD; Herrmann G
Antiviral Res; 1986 Mar; 6(2):83-93. PubMed ID: 3010858
[TBL] [Abstract][Full Text] [Related]
3. Antiherpes activity of some novel analogues of (E)-5-(2-bromovinyl)-2'-deoxyuridine (E-BrVUdR) in two different cell lines.
Reefschläger J; Bärwolff D; Herrmann G; Langen P
Acta Virol; 1984 Jan; 28(1):1-10. PubMed ID: 6143491
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity of 5-ethyl-2'-deoxyuridine against herpes simplex viruses in cell culture, mice, and guinea pigs.
Schinazi RF; Scott RT; Peters J; Rice V; Nahmias AJ
Antimicrob Agents Chemother; 1985 Oct; 28(4):552-60. PubMed ID: 3000291
[TBL] [Abstract][Full Text] [Related]
5. [(E)-5-(2-bromovinyl)-2'-desoxyuridine--a new nucleoside analog with selective inhibitory action against herpesviruses. Studies in cell culture and animal experiments].
Reefschläger J; Wutzler P; Thiel KD; Töpke H; Bärwolff D; Langen P
Pharmazie; 1987 Jun; 42(6):407-11. PubMed ID: 2823299
[TBL] [Abstract][Full Text] [Related]
6. Efficiency and selectivity of (E)-5-(2-bromovinyl)-2'-deoxyuridine and some other 5-substituted 2'-deoxypyrimidine nucleosides as anti-herpes agents.
Reefschläger J; Brwolff D; Bärwolff D; Langen P; Rosenthal HA
Antiviral Res; 1982 May; 2(1-2):41-52. PubMed ID: 6285818
[TBL] [Abstract][Full Text] [Related]
7. Problems associated with the use of (E)-5-(2-bromovinyl)-2'-deoxyuridine for typing herpes simplex virus.
Swierkosz EM; Arens MQ; Rivetna KA
J Clin Microbiol; 1985 Mar; 21(3):459-61. PubMed ID: 2984249
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of 5-vinyl-1-beta-D-arabinofuranosyluracil (VaraU) against herpes simplex virus type 2 strains in cell cultures and against experimental herpes encephalitis in mice: comparison with acyclovir and foscarnet.
Reefschläger J; Wutzler P; Thiel KD; Herrmann G
Pharm Res; 1987 Jun; 4(3):200-6. PubMed ID: 2855541
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of herpes simplex virus types 1 and 2 by sensitivity to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Mayo DR
J Clin Microbiol; 1982 Apr; 15(4):733-6. PubMed ID: 6279696
[TBL] [Abstract][Full Text] [Related]
10. Preclinical assessment of topical treatments of herpes simplex virus infection: 5% (E)-5-(2-bromovinyl)-2'-deoxyuridine cream.
Freeman DJ; Sacks SL; De Clercq E; Spruance SL
Antiviral Res; 1985 Jun; 5(3):169-77. PubMed ID: 2992371
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil (BrVaraU, VaraU) in the treatment of experimental herpes simplex virus type 1 keratitis in rabbits: comparison with (E)-5-(2-bromovinyl)-2'-deoxyuridine (BrVUdR).
Töpke H; Gräf M; Wutzler P; Herrmann G; Reefschläger J
Antiviral Res; 1988 Jul; 9(4):273-80. PubMed ID: 3202622
[TBL] [Abstract][Full Text] [Related]
12. Differential antiherpes activity of the (E)-and (Z)-isomers of 5-(2-fluorovinyl)-2'-deoxyuridine (FVUdR).
Reefschläger J; Bärwolff D; Langen P
Acta Virol; 1984 Jul; 28(4):282-6. PubMed ID: 6148852
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus type 1 that exhibits herpes simplex virus type 2 sensitivity to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Docherty JJ; Dobson AT; Trimble JJ; Jennings BA
Intervirology; 1991; 32(5):308-15. PubMed ID: 1657822
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus.
De Clercq E; Descamps J; Verhelst G; Walker RT; Jones AS; Torrence PF; Shugar D
J Infect Dis; 1980 May; 141(5):563-74. PubMed ID: 6246180
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiviral properties of (Z)-5-(2-bromovinyl)-2'-deoxyuridine.
Jones AS; Rahim SG; Walker RT; De Clercq E
J Med Chem; 1981 Jun; 24(6):759-60. PubMed ID: 6265638
[TBL] [Abstract][Full Text] [Related]
16. Selective in vitro and in vivo activities of 5-(2-haloalkyl)pyrimidine nucleoside analogs, particularly 5-(2-chloroethyl)-2'-deoxyuridine, against herpes simplex virus.
De Clercq E; Rosenwirth B
Antimicrob Agents Chemother; 1985 Aug; 28(2):246-51. PubMed ID: 3010841
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with trifluorothymidine, phosphonoformate and acycloguanosine against herpes simplex viruses.
Ayisi NK; Gupta SV; Babiuk LA
Antiviral Res; 1985 Feb; 5(1):13-27. PubMed ID: 2984988
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiviral activity of (E)-5-(2-bromovinyl)uracil and (E)-5-(2-bromovinyl)uridine.
De Clercq E; Desgranges C; Herdewijn P; Sim IS; Jones AS; McLean MJ; Walker RT
J Med Chem; 1986 Feb; 29(2):213-7. PubMed ID: 3005566
[TBL] [Abstract][Full Text] [Related]
19. Effect of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (brovavir) on experimental infections in mice with herpes simplex virus type 1 strains of different degrees of virulence.
Machida H; Takezawa J
Antimicrob Agents Chemother; 1990 May; 34(5):691-6. PubMed ID: 2163240
[TBL] [Abstract][Full Text] [Related]
20. Intentional reactivation of latent ocular herpes infection during BVDU therapy.
Trousdale MD; Robin JB; Willey DE; De Clercq E
Curr Eye Res; 1987 Dec; 6(12):1471-7. PubMed ID: 2827960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
